Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending T
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
bacteria infections
Research
Harmless skin bacteria engineered to be living topical vaccine
When mice were colonized by these bacteria, they developed immunity to tetanus that prevented them from dying when later exposed to the toxin.
Darren Incorvaia
Dec 11, 2024 11:00am
Chlamydia in gut cells could require new antibiotic approach
Sep 5, 2024 5:00am
New antibiotic kills flesh-eating bacteria in preclinical study
Aug 2, 2024 2:00pm
BiomX acquires fellow bacteria-killing virus company APT
Mar 6, 2024 9:01am
Meet Phaxiam: Erytech's merger with Pherecydes is complete
Jun 26, 2023 2:10pm
Venatorx hits goal in antibiotic phase 3, clearing path to FDA
Mar 10, 2022 8:25am